bioRxiv/medRxiv TRiP Review Activity

413 Reviews — All Partners — Cancer Biology

Most recent first Previous | Page 23: Articles 221-230 | Next

Single-cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastoma

Finotto, L., Cole, B., Giese, W., Baumann, E., Claeys, A., Vanmechelen, M., Decraene, B., Derweduwe, M., Dubroja Lakic, N., Shankar, G., Nagathihalli Kantharaju, M., Albrecht, J. P., Geudens, I., Stanchi, F., Ligon, K. L., Boeckx, B., Lambrechts, D., Harrington, K., Van Den Bosch, L., De Vleeschouwer, S., De Smet, F., Gerhardt, H.

10.1101/2023.04.27.538517 — Posted: 2023-05-01 — Discussion: 2023-06-09 Review Commons

RAS and PP2A activities converge on epigenetic gene regulation

Aakula, A., Sharma, M., Tabaro, F., Honkanen, H., Schapira, M., Arrowsmith, C., Nykter, M., Westermarck, J.

10.1101/2022.05.11.491459 — Posted: 2022-05-12 — Discussion: 2023-05-26 EMBO Press

Cancers adapt to their mutational load by buffering protein misfolding stress

Tilk, S., Frydman, J., Curtis, C., Petrov, D.

10.1101/2022.06.08.495407 — Posted: 2022-06-10 — Discussion: 2023-05-22 eLife

ROR1 plays a critical role in pancreatic tumor-initiating cells with a partial EMT signature.

Yamazaki, M., Hino, S., Usuki, S., Miyazaki, Y., Oda, T., Nakao, M., Ito, T., Yamagata, K.

10.1101/2022.07.13.499868 — Posted: 2022-07-14 — Discussion: 2023-05-19 EMBO Press

MLL3 regulates the CDKN2A tumor suppressor locus in liver cancer

Soto-Feliciano, Y. M., Zhu, C., Morris, J. P., Huang, C.-h., Koche, R. P., Ho, Y.-j., Banito, A., Chen, C.-w., Shroff, A., Tian, S., Geulah, L., Chen, C.-c., Fennell, M., Armstrong, S., Allis, C. D., Tschaharganeh, D., Lowe, S. W.

10.1101/2022.06.07.495174 — Posted: 2022-06-09 — Discussion: 2023-05-10 eLife

β-catenin activity induces an RNA biosynthesis program promoting therapy resistance in T Acute Lymphoblastic Leukemia

Garcia-Hernandez, V., Arambilet, D., Guillen, Y., Lobo, T., Gekas, C., Vega-Garcia, N., Sentis, I., Trincado, J. L., Marquez-Lopez, I., Heyn, H., Camos, M., Espinosa, L., Bigas, A.

10.1101/2022.07.07.499249 — Posted: 2022-07-09 — Discussion: 2023-04-27 EMBO Press

An RNA-binding switch drives ribosome biogenesis and tumorigenesis downstream of RAS oncogene

Azman, M. S., Dodel, M., Capraro, F., Faraway, R., Dermit, M., Fan, W., Ule, J., Mardakheh, F. K.

10.1101/2021.12.16.472890 — Posted: 2021-12-16 — Discussion: 2023-04-25 EMBO Press

Comprehensive characterization of tumor microenvironment in colorectal cancer via histopathology-molecular analysis

Wu, X., Yan, H., Qiu, M., Qu, X., Wang, J., Xu, S., Zheng, Y., Ge, M., Yan, L., Liang, L.

10.1101/2023.02.16.528849 — Posted: 2023-02-20 — Discussion: 2023-04-23 eLife

Inhibitors of ROCK kinases induce multiple mitotic defects and synthetic lethality in BRCA2-deficient cells

Martino, J., Siri, S. O., Paviolo, N. S., Garro, C., Pansa, M. F., Carbajosa, S., Brown, A., Bocco, J. L., Gloger, I., Drewes, G., Madauss, K. P., Soria, G., Gottifredi, V.

10.1101/2022.06.24.497514 — Posted: 2022-06-28 — Discussion: 2023-04-20 eLife

FOXP2 confers oncogenic effects in prostate cancer through activating MET signalling

Zhu, X., Chen, C., Wei, D., Xu, Y., Liang, S., Jia, W., Li, J., Qu, Y., Zhai, J., Zhang, Y., Wu, P., Hao, Q., Zhang, L., Zhang, W., Yang, X., Pan, L., Qi, R., Li, Y., Wang, F., Yi, R., Yang, Z., Wang, J., Zhao, Y.

10.1101/2022.07.06.498943 — Posted: 2022-07-06 — Discussion: 2023-04-06 eLife